You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,807 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Active, not recruiting
  • Small Cell Lung Cancer
  • ETOPOSIDE - Usual
  • ETOPOSIDE - Study
  • North Bethesda, Maryland
    Medicine Invention Design, Inc. (MIDI) - IORG0007849
2021-08-30
Aug 30, 2021
B
Active, not recruiting
  • COVID-19
  • Etoposide
  • Boston, Massachusetts
    Boston Medical Center
2022-01-07
Jan 7, 2022
A
Recruiting
  • Glioblastoma Multiforme
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
2022-03-28
Mar 28, 2022
P
Completed
  • Effect of Drug
  • +2 more
  • Apatinib Mesylate
  • ifosfamide and etoposide
  • Beijing, Beijing, China
    Peking University People's Hospital
2022-03-12
Mar 12, 2022
B
Recruiting
  • Recurrent Medulloblastoma
  • Apatinib Combined With Temozolomide and Etoposide Capsules
  • Beijing, China
    Beijing Sanbo Brain Hospital
2022-02-10
Feb 10, 2022
M
Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-02-02
Feb 2, 2022
N
Recruiting
  • Germ Cell Tumor
  • +2 more
  • Etoposide
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
2022-02-23
Feb 23, 2022
U
Completed
  • Leukemia
  • +2 more
  • Gainesville, Florida
    UF Health Shands Cancer Hospital
2022-01-20
Jan 20, 2022
L
Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • ZKAB001
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
2021-09-08
Sep 8, 2021
C
Recruiting
  • Triple Negative Breast Cancer
  • oral etoposide + anlotinib
  • Beijing, China
    Cancer Institute & Hospital. Chinese Academy of Medical Sciences
2021-07-15
Jul 15, 2021
B
Active, not recruiting
  • Small Cell Lung Cancer
  • Barcelona, Spain
  • +3 more
2021-11-08
Nov 8, 2021
K
Recruiting
  • Acute Myeloid Leukemia
  • mitoxantrone + etoposide + gemtuzumab ozogamicin
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
2022-02-09
Feb 9, 2022
S
Not yet recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Washington, District of Columbia
  • +1 more
2022-03-28
Mar 28, 2022
T
Recruiting
  • Brain Tumor Recurrent
  • Houston, Texas
    UTHealth & Children's Memorial Hermann Hospital
2021-10-27
Oct 27, 2021
S
Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
2021-06-03
Jun 3, 2021
P
Recruiting
  • Neuroendocrine Tumors
  • Neuroendocrine Carcinoma
  • Beijing, Beijing, China
  • +2 more
2021-11-02
Nov 2, 2021
S
Recruiting
  • Treatment Refusal
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
2020-12-16
Dec 16, 2020
Q
Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
2022-03-25
Mar 25, 2022
S
Active, not recruiting
  • Testicular Neoplasms
  • Seminoma
  • Trondheim, Norway
    Institutt for kreftforskning og molekylær medisin, St Olavs Hosp
2021-11-05
Nov 5, 2021
O
E
Recruiting
  • Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Atlanta, Georgia
  • +3 more
2021-07-15
Jul 15, 2021
S
Recruiting
  • Acute Lymphoblastic Leukemia
  • Seoul, Daehangno, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
2021-06-15
Jun 15, 2021